372 filings
Page 5 of 19
4
NRXP
NRX Pharmaceuticals Inc
22 Nov 22
NRX Pharmaceuticals / Patrick John Flynn ownership change
5:44pm
4
NRXP
NRX Pharmaceuticals Inc
21 Nov 22
NRX Pharmaceuticals / Chaim Hurvitz ownership change
5:58pm
4
Daniel C. Javitt
18 Nov 22
NRX Pharmaceuticals / Daniel C. Javitt ownership change
7:05pm
4
NRXP
NRX Pharmaceuticals Inc
15 Nov 22
NRX Pharmaceuticals / Daniel C. Javitt ownership change
7:40pm
8-K
NRXP
NRX Pharmaceuticals Inc
14 Nov 22
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements
6:51am
10-Q
2022 Q3
NRXP
NRX Pharmaceuticals Inc
Quarterly report
14 Nov 22
12:00am
8-K
NRXP
NRX Pharmaceuticals Inc
9 Nov 22
NRx Pharmaceuticals Closes $11 Million Unsecured Debt Financing
5:22pm
SC 13D
Daniel C. Javitt
13 Sep 22
NRX Pharmaceuticals / Javitt Daniel C. ownership change
4:47pm
8-K
NRXP
NRX Pharmaceuticals Inc
22 Aug 22
Other Events
5:12pm
10-Q
2022 Q2
NRXP
NRX Pharmaceuticals Inc
Quarterly report
15 Aug 22
5:56pm
8-K
NRXP
NRX Pharmaceuticals Inc
12 Aug 22
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:01pm
4
Daniel C. Javitt
2 Aug 22
NRX Pharmaceuticals / Daniel C. Javitt ownership change
5:43pm
8-K
NRXP
NRX Pharmaceuticals Inc
28 Jul 22
Departure of Directors or Certain Officers
5:02pm
424B7
NRXP
NRX Pharmaceuticals Inc
25 Jul 22
Prospectus with selling stockholder info
5:17pm
3
NRXP
NRX Pharmaceuticals Inc
22 Jul 22
NRX Pharmaceuticals / Stephen H Willard ownership change
4:27pm
8-K
NRXP
NRX Pharmaceuticals Inc
21 Jul 22
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
NRXP
NRX Pharmaceuticals Inc
15 Jul 22
NRx Pharmaceuticals Announces the Appointment of Stephen Willard, Chief Executive Officer and Director
5:03pm
4
NRXP
NRX Pharmaceuticals Inc
5 Jul 22
NRX Pharmaceuticals / Daniel C. Javitt ownership change
5:06pm